Omega-3 fatty acids and blood pressure

Cellular and Molecular Biology

Volumn 56, Issue 1, 2010, Pages 83-92

  Mori, T A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Blood pressure; Hypertension; Omega 3 fatty acids; Vascular function

Indexed keywords

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOCOSAHEXAENOIC ACID; FISH OIL; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; INDOMETACIN; NITROPRUSSIDE SODIUM; OMEGA 3 FATTY ACID; PLATELET DERIVED GROWTH FACTOR; PROSTACYCLIN; SEROTONIN; THROMBIN; THROMBOXANE; ANTIHYPERTENSIVE AGENT; CATECHOLAMINE;

AEROBIC EXERCISE; ANTIHYPERTENSIVE ACTIVITY; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DRUG MECHANISM; DYSLIPIDEMIA; FAT INTAKE; FOOD INTAKE; FRUIT; HEART RATE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; META ANALYSIS; MICROCIRCULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; SALT INTAKE; SMOOTH MUSCLE FIBER; SODIUM RESTRICTION; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VEGETABLE; WEIGHT CONTROL; WEIGHT REDUCTION; ANIMAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; ENDOTHELIUM; FEMALE; HEALTH SURVEY; PHYSIOLOGY; RAT; VASODILATATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CATECHOLAMINES; CONTROLLED CLINICAL TRIALS AS TOPIC; ENDOTHELIUM; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; META-ANALYSIS AS TOPIC; POPULATION SURVEILLANCE; RATS; VASODILATION;

EID: 77953626923     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T881     Document Type: Article

References (103)

1. Appel, L. J., Miller, E. R. III., Seidler, A.J. and Whelton, P.K., Does supplementation of diet with 'fish oil' reduce blood pressure? Arch. Inter. Med. 1993; 153: 1429-1438.
2. Bao, D. Q., Mori, T. A., Burke, V., Puddey, I. B. and Beilin, L. J., Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension 1998; 32: 710-717.
3. Beilin, L. J. and Mori, T. A., Dietary ω3 fatty acids. In: Lifestyle Modification for the Prevention and Treatment of Hypertension, Whelton, P. K., He, J. and Louis, G. T. (eds.), Marcel Dekker, Inc., New York, USA. 2003, 275-300.
4. Billman, G. E., Hallaq, H. and Leaf, A., Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc. Natl. Acad. Sci. USA 1994; 91(10): 4427-4430.
5. Bonaa, K. H., Bjerve, K. S., Straume, B., Gram, I. T. and Thelle, D., Effect of eicosapentaenoic acid and docosahexaenoic acid on blood pressure in hypertension. A population based intervention trial from the Tromso study. N. Engl. J. Med. 1990; 322: 795-801.
6. Boulanger, C., Schini, V. B., Hendrickson, H. and Vanhoutte, P. M., Chronic exposure of cultured endothelial cells to eicosapentaenoic acid potentiates the release of endothelium-derived relaxing factor(s). Br. J. Pharmacol. 1990; 99: 176-180.
7. Bucher, H. C., Hengstler, P., Schindler, C. and Meier, G., N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am. J. Med. 2002; 112: 298-304.
8. Calder, P. C., Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001, 36: 1007-1024.
9. Chin, J. P., Marine oils and cardiovascular reactivity. Prost. Leuk. Essent. Fatty. Acids. 1994; 50: 211-222.
10. Chin, J. P. F. and Dart, A. M., Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: effect of fish oils. Clin. Exp. Pharmacol. Physiol. 1994; 21: 749-755.
11. Chin, J. P. and Dart, A. M., How do fish oils affect vascular function? Clin. Exper. Pharm. Physiol. 1995; 22: 71-81.
12. Chin, J. P. F., Gust, A. P. and Dart, A. M., Indomethacin inhibits the effects of dietary supplementation with fish oils on vasoconstriction of human forearm resistance vessels in vivo. J. Hypertension 1993; 11: 1229-1234.
13. Chin, J. P. F., Gust, A. P., Nestel, P. J. and Dart, A. M., Fish oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993; 21: 22-28.
14. Christensen, J. H., n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability. Danish. Med. Bull. 2003; 50(4): 347-367.
15. Christensen, J. H. and Schmidt, E. B., n-3 fatty acids and the risk of sudden cardiac death. Lipids 2001; 36 Suppl: S115-S118.
16. Chu, Z. M., Yin, K. and Beilin, L. J., Fish oil feeding selectively attenuates contractile responses to noradrenaline and electrical stimulation in the perfused mesenteric resistance vessels of spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 1992; 19: 177-181.
17. Cobiac, L., Nestel, P. J., Wing, L. M. and Howe, P. R. C., A low sodium diet supplemented with fish oil lowers blood pressure in the elderly. J. Hypertens. 1992; 10: 87-92.
18. Dallongeville, J., Yarnell, J., Ducimetiere, P., Arveiler, D., Ferrieres, J., Montaye, M., Luc, G., Evans, A., Bingham, A., Hass, B., Ruidavets, J. B. and Amouyel, P., Fish consumption is associated with lower heart rates. Circulation 2003; 108(7): 820-825.
19. Dickinson, H. O., Mason, J. M., Nicolson, D. J., Campbell, F., Beyer, F. R., Cook, J. V., Williams, B. and Ford, G.A., Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J. Hypertens. 2006; 24(2): 215-233.
20. Dokholyan, R. S., Albert, C. M., Appel, L. J., Cook, N. R., Whelton, P. K. and Hennekens, C. H., A trial of omega-3 fatty acids for prevention of hypertension. Am. J. Cardiol. 2004; 93(8): 1041-1043.
21. Engler, M. B., Engler, M. M. and Ursell, P. C., Vasorelaxant properties of n-3 polyunsaturated fatty acids in aortas from spontaneously hypertensive and normotensive rats. J. Cardiovasc. Risk. 1994; 1: 75-80.
22. 3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5 ω3). Biochem. Biophys. Res. Commun. 1983; 116(3): 1091-1099.
23. 3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 1984; 307(5947): 165-168.
24. Fleischhauer, F. J., Yan, W-D. and Fischell, T. A., Fish oil improves endothelium-dependent coronary vasodilation in heart transplant recipients. J. Amer. Coll. Cardiol. 1993; 21: 982-989.
25. Fox, P. L. and DiCorleto, P. E., Fish oils inhibit endothelial cell production of platelet-derived growth factor like protein. Science 1988; 241: 453-546.
26. Geleijnse, J. M., Giltay, E. J., Grobbee, D. E., Donders, A. R. T. and Kok, F. J., Blood pressure response to fish oil supplementation: meta-regression analysis of randomized trials. J. Hypertens. 2002; 20: 1493-1499.
27. GISSI-Prevenzione Investigators, Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI- Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999; 354: 447-455.
28. Goodfellow, J., Bellamy, M. F., Ramsey, M. W., Jones, C. J. and Lewis, M. J., Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J. Am. Coll. Cardiol. 2000; 35(2): 265-270.
29. Gray, D. R., Gozzip, C. G., Eastham, J. H. and Kashyap, M. L., Fish oil as an adjuvant in the treatment of hypertension. Pharmacotherapy 1996; 16: 295-300.
30. Grimsgaard, S., Bonaa, K. H., Hansen, J. B. and Myhre, E. S. P., Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am. J. Clin. Nutr. 1998; 68: 52-59.
31. Grimsgaard, S., Bonaa, K. H., Hansen, J. B. and Nordoy, A., Highly purified eicosapentaenic acid and docosahexaenic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am. J. Clin. Nutr. 1997; 66: 649-659.
32. Harris, W. S., n-3 Fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 1996; 31: 243-252.
33. Harris, W. S., n-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 1997; 65(5 Suppl): 1645S-54S.
34. Harris, W. S., Rambjor, G. S., Windsor, S. L. and Diederich, D., n-3 Fatty acids and urinary excretion of nitric oxide metabolites in humans. Am. J. Clin. Nutr. 1997; 65: 459-464.
35. Hashimoto, M., Hossain, M. S., Yamasaki, H., Yazawa, K. and Masumura, S., Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells. Lipids 1999; 34: 1297-1204.
36. Hashimoto, M., Shinozuka, K., Gamoh, S., Tanabe, Y., Hossain, M. S., Kwon, Y. M., Hata, N., Misawa, Y., Kunitomo, M. and Masumura, S., The hypotensive effect of docosahexaenoic acid is associated with the enhanced release of ATP from the caudal artery of aged rats. J. Nutr. 1999; 129: 70-76.
37. He, K., Song, Y., Daviglus, M. L., Liu, K., Van Horn, L., Dyer, A. R., Goldbourt, U. and Greenland, P., Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke 2004; 35(7): 1538-42.
38. He, K., Song, Y., Daviglus, M. L., Liu, K., Van Horn, L., Dyer, A.R. and Greenland, P., Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation, 2004; 109: 2705-2711.
39. Howe, P., Lungershausen, Y., Cobiac, L., Dandy, G. and Nestel, P., Effect of sodium restriction and fish oil supplementation on BP and thrombotic risk factors in patients treated with ACE inhibitors. J. Human. Hypertens. 1994; 8: 43-49.
40. Knapp, H. R., Dietary fatty acids in human thrombosis and hemostasis. Am. J. Clin. Nutr. 1997; 65: 1687S-198S.
41. Knapp, H. R. and FitzGerald, G. A., The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N. Engl. J. Med. 1989; 320: 1037-1043.
42. Knapp, H. R., Reilly, I. A., Alessandrini, P. and FitzGerald, G.A., In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N. Engl. J. Med. 1986;314(15): 937-942.
43. Kris-Etherton, P. M., Harris, W. S., Appel, L. J., for the Nutrition Committee, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 1-12.
44. Leaf, A., Kang, J. X., Xiao, Y. F. and Billman, G. E., Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003; 107: 2646-2652.
45. Levinson, P. D., Iosiphidis, A. H., Saritelli, A. L., Herbert, P. N. and Steiner, M., Effects of n-3 fatty acids in essential hypertension. Am. J. Hypertens. 1990; 3: 754-760.
46. Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., Karanja, N., Lefevre, M., Rudel, L., Sacks, F., Van Horn, L., Winston, M. and Wylie-Rosett, J., Diet and lifestyle recommendations revision 2006 - A scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114(1): 82-96.
47. Lorenz, R., Spengler, U., Fischer, S., Duhm, J. and Weber, P. C., Platelet function, thromboxane formation and blood pressure control during supplementation of the western diet with cod liver oil. Circulation 1983; 67: 504-511.
48. Lungershausen, Y. K., Abbey, M., Nestel, P. J. and Howe P. R., Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J. Hypertens. 1994; 12: 1041-1045.
49. Margolin, G., Huster, G., Glueck, C.J., Speirs, J., Vandegrift, J., Illig, E., Wu, J., Streicher, P. and Tracy, T., Blood pressure lowering in elderly subjects: a double-blind crossover study of omega-3 and omega-6 fatty acids. Am. J. Clin. Nutr. 1991; 53: 562-572.
50. McLennan, P. L., Barnden, L. R., Bridle, T. M., Abeywardena, M. Y. and Charnock, J. S., Dietary fat modulation of left ventricular ejection fraction in the marmoset due to enhanced filling. Cardiovasc. Res. 1992; 26: 871-877.
51. McLennan, P., Howe, P., Abeywardena, M., Muggli, R., Raederstorff, D., Mano, M., Rayner, T. and Head, R., The cardiovascular protective role of docosahexaenoic acid. Euro. J. Pharmacol. 1996; 300: 83-89.
52. McVeigh, G. E., Brennan, G. M., Cohn, J. N., Finkelstein, S. M., Hayes, R. J. and Johnston, G. D., Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler. Thromb. 1994; 14: 1425-1429.
53. McVeigh, G. E., Brennan, G. M., Johnston, G. D., McDermott, B. J., McGrath, L. T., Henry, W. R., Andrews, J. W. and Hayes, J. R., Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1993; 36: 33-38.
54. Mori, T. A., Bao, D. Q., Burke, V., Puddey, I. B. and Beilin, L. J., Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999; 34: 253-260.
55. Mori, T. A., Bao, D. Q., Burke, V., Puddey, I. B., Watts, G. F., O'Neal, D. N., Best, J. D. and Beilin, L. J., Purified eicosapentaenoic acid and docosahexaenoic acid have differential effects of on serum lipids and lipoproteins, LDL - particle size, glucose and insulin, in mildly hyperlipidaemic men. Am, J, Clin, Nutr, 2000; 71: 1085-1094.
56. Mori, T. A. and Beilin, L. J., Long chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Curr. Opin. Lipidol. 2001; 12: 11-17.
57. Mori, T. A. and Beilin, L. J., ω3 Fatty acids and inflammation. Curr. Atherosclerosis. Rep. 2004; 6: 461-467.
58. Mori, T. A., Watts, G. F., Burke, V., Bao, D. Q., Hilme, E., Beilin, L. J. and Puddey, I. B., Differential effects of eicosapentaenoic acid and docosahexaenoic acid on forearm vascular reactivity of the microcirculation in hyperlipidaemic, overweight men. Circulation 2000; 102: 1264-1269.
59. Mori, T.A. and Woodman, R.J., The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr. Opin. Clin. Nutr. Metab. Care. 2006; 9: 95-104.
60. Morris, M. C., Sacks, F. and Rosner, B., Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993; 88: 523-533.
61. Mozaffarian, D., Geelen, A., Brouwer, I. A., Geleijnse, J. M., Zock, P. L. and Katan, M. B., Effect of fish oil on heart rate in humans - A meta-analysis of randomized controlled trials. Circulation 2005; 112(13): 1945-1952.
62. Nestel, P., Shige, H., Pomeroy, S., Cehun, M., Abbey, M. and Raederstorff, D., The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am..J. Clin. Nutr. 2002; 76: 326-330.
63. Nishimura, M., Nanbu, A., Komori, T., Ohtsuka, K., Takahashi, H. and Yoshimura, M., Eicosapentaenoic acid stimulates nitric oxide production and decreases cardiac noradrenaline in diabetic rats. Clin. Exper. Pharm. Physiol. 2007; 27(8): 618-624.
64. Norris, P. G., Jones, C. J. and Weston, M. J., Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension. B.M.J. 1986; 293: 104-105.
65. Panagiotakos, D., Zeimbekis, A., Boutziouka, V., Economou, M., Kourlaba, G. and Toutouzas, P., Polychronopoulos E. Long-term fish intake is associated with better lipid profile, arterial blood pressure, and blood glucose levels in elderly people from Mediterranean islands (MEDIS epidemiological study). Med. Sci. Monit. 2007; 13(7): 307-312.
66. Pauletto, P., Puato, M., Caroli, M. G., Casiglia, E., Munhambo, A. E., Cazzolato, G., Bon, G. B., Angeli, M. T., Galli, C. and Pessina, A. C., Blood pressure and atherogenic lipoprotein profiles of fish-diet and vegetarian villagers in Tanzania: the Lugalawa study. Lancet 1996; 348: 784-788.
67. Prisco, D., Paniccia, R., Bandinelli, B., Filippini, M., Francalanci, I., Giusti, B., Giurlani, L., Gensini, G. F., Abbate, R. and Neri Serneri, G. G., Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb. Res. 1998; 91: 105-112.
68. Radack, K., Deck, C. and Huster, G., The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. A randomized controlled trial. Arch. Intern. Med. 1991; 151: 1173-1180.
69. Rambjor, G. S., Walen, A. I., Windsor, S. L. and Harris, W.S., Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids 1996; 31: S45-S49.
70. Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R. III., Simons-Morton, D. G., Karanja, N. and Lin, P. H., DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. New. Engl. J. Med. 2001; 344(1): 3-10.
71. Schini, V. B., Durante, W., Catovsky, S. and Vanhoutte, P. M., Eicosapentaenoic acid potentiates the production of nitric oxide evoked by interleukin-1β in cultured vascular smooth muscle cells. J. Vasc. Res. 1993; 30: 209-217.
72. BB in vascular smooth muscle cells. Eur. J. Pharmacol. 1992; 216: 379-383.
73. Schmidt, E. B., Arnesen, H., Christensen, J. H., Rasmussen, L. H., Kristensen, S. D. and De Caterina, R., Marine n-3 polyunsaturated fatty acids and CHD: Part II. Clinical trials and recommendations. Thromb. Res. 2005; 115: 257-262.
74. Schmidt, E. B., Arnesen, H., de Caterina, R., Rasmussen, L.H. and Kristensen, S.D., Marine n-3 polyunsaturated fatty acids and CHD: Background, epidemiology, animal data, effects on risk factors and safety. Thromb. Res. 2005; 115: 163-170.
75. Shimokawa, H., Lam, J. Y. T., Chesebro, J. H., Bowie, E. J. W. and Vanhoutte, P. M., Effects of dietary supplementation with cod-liver oil on endothelium-dependent response in porcine coronary arteries. Circulation 1987; 76: 898-905.
76. Shimokawa, H. and Vanhoutte, P. M., Dietary cod-liver oil improves endothelium-dependent response in hypercholesterolaemic and atherosclerotic porcine arteries. Circulation 1988; 78: 1421-1430.
77. Singer, P., Berger, I., Luck, K., Taube, C., Naumann, E. and Godicke, W., Long-term effect of mackerel diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension. Atherosclerosis 1986; 62: 259-265.
78. Singer, P., Melzer, S., Goschel, M. and Augustin, S., Fish oil amplifies the effect of propranolol in mild essential hypertension. Hypertension 1990; 16: 682-691.
79. Stamler, J., Rose, G., Stamler, R., Elliott, P., Dyer, A. and Marmot, M., INTERSALT study findings - public-health and medical-care implications. Hypertension 1989; 14(5): 570-577.
80. Toft, I., Bonna, K. H., Ingebretsen, O. C., Nordoy, A. and Jenssen, T., Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann. Intern. Med. 1995; 123: 911-918.
81. Ueshima, H., Stamler, J., Elliott, P., Chan, Q., Brown, I. J., Carnethon, M. R., Daviglus, M. L., He, K., Moag-Stahlberg, A., Rodriguez, B. L., Steffen, L. M., Van Horn, L., Yarnell, J. and Zhou, B., Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure INTERMAP study. Hypertension 2007; 50(2): 313-319.
82. Vandongen, R., Mori, T. A., Burke, V., Beilin, L. J., Morris, J. and Ritchie, J., Effects on blood pressure of ω3 fats in subjects at increased risk of cardiovascular disease. Hypertension 1993; 22: 371-379.
83. Vekshtein, V. I., Yeung, A. C., Vita, J. A., Nabel, E. G., Fish, R. D., Bittl, J. A., Selwyn, A. P. and Ganz, P., Fish oil improves endothelium-dependent relaxation in patients with coronary artery disease. Circulation 1989; 80(Suppl II): II-434.
84. Wang, C. C., Harris, W. S., Chung, M., Lichtenstein, A. H., Balk, E. M., Kupelnick, B., Jordan, H. S. and Lau, J., n-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am. J. Clin. Nutr. 2006; 84(1): 5-17.
85. Whelton, S. P., He, J., Whelton, P. K. and Muntner, P., Meta-analysis of observational studies on fish intake and coronary heart disease. Am. J. Cardiol. 2004; 93: 1119-1123.
86. Wing, L. M., Nestel, P. J., Chalmers, J. P., Rouse, I., West, M. J., Bune, A, J., Tonkin, A. L. and Russell, A. E., Lack of effect of fish oil supplementation on blood pressure in treated hypertensives. J. Hypertens. 1990; 8: 339-343.
87. Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Barden, A., Watts, G. F. and Beilin, L. J., Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrilolytic and vascular function in Type 2 diabetic patients. Atherosclerosis 2003; 166: 85-93.
88. Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F. and Beilin, L. J., Effects of purified eicosapentaenoic acid and docosahexaenoic acid on glycaemic control, blood pressure and serum lipids in treated-hypertensive Type 2 diabetic patients. Am. J. Clin. Nutr. 2002; 76: 1007-1015.
89. Yin, K., Chu, Z. M. and Beilin, L. J., Blood pressure and vascular reactivity changes in spontaneously hypertensive rats fed fish oil. Br. J. Pharmacol. 1991; 102: 991-997.
90. Yin, K., Chu, Z. M. and Beilin, L. J., Study of mechanisms of glucocorticoid hypertension in rats: Endothelial related changes and their amelioration by dietary fish oils. Brit. J. Pharmacol. 1992; 106: 435-442.
91. Yoshimura, T., Matsui, K., Ito, M., Yunohara, T., Kawasaki, N., Nakamura, T. and Okamura, H., Effects of highly purified eicosapentaenoic acid on plasma beta thromboglobulin level and vascular reactivity to angiotensin II. Artery 1987; 14: 295-303.
92. Andersen, V.L., Vogt, J., Obel, T., Christensen, J.H., Schmidt, E.B., The effect of n-3 fatty acids on plasma myeloperoxidase levels in healthy adults. Cell. Mol. Biol. 2010, 56(1): 3-9.
93. Andreasen, J. J., Aardestrup, I. V., Eschen, R. B., Obel, T., Lundbye-Christensen, S., Schmidt, E. B., Fatty acid composition of the internal mammary artery in relation to dietary intake of marine n-3 polyunsaturated fatty acids and association with flow-mediated vasodilation. Cell. Mol. Biol. 2010, 56(1): 10-17.
94. Arnesen, H., Seljeflot, I., Studies on very long chain marine n-3 fatty acids in patients with atherosclerotic heart disease with special focus on mechanisms, dosage and formulas of supplementation. Cell. Mol. Biol. 2010, 56(1): 18-27.
95. Calder, P.C., Yaqoob, P., Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques. Cell. Mol. Biol. 2010, 56(1): 28-37.
96. Petersen, M.M., Eschen, R.B., Aardestrup, I., Obel, T., Schmidt, E.B., Flow-mediated vasodilation and dietary intake of n-3 polyunsaturated acids in healthy subjects. Cell. Mol. Biol. 2010, 56(1): 38-44.
97. Eschen, O., Christensen, J.H., La rovere, M.T., Romano, P., Sala, P., Schmidt, E.B., Effects of marine n-3 fatty acids on circulating levels of soluble adhesion molecules in patients with chronic heart failure. Cell. Mol. Biol. 2010, 56(1): 45-51.
98. Isherwood, C, Wong, M., Jones, W.S., Davies, I.G., Griffin, B.A., lack of effect of cold water prawns on plasma cholesterol and lipoproteins in normo-lipidaemic men. Cell. Mol. Biol. 2010, 56(1): 52-58.
99. Massaro, M., Scoditti, E., Carluccio, M. A., Campana, M. C, De caterina, R., Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils. Cell. Mol. Biol. 2010, 56(1): 59-82.
100. Von Schacky, C, Omega-3 fatty acids vs. cardiac disease - the contribution of the omega-3 index. Cell. Mol. Biol. 2010, 56(1): 93-101.
101. 2-macroglobulin in healthy subjects after supplementation with different doses of marine n-3 fatty acids. Cell. Mol. Biol. 2010, 56(1): 102-109.
102. Marchioli, R., Silletta, M.G., Levantesi, G., Pioggiarella, R., Tognoni, G., N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence. Cell. Mol. Biol. 2010, 56(1): 110-130.
103. Christensen, J.H., Svensson, M., Strandhave, C, Madsen, T., Schmidt, E.B., N-3 fatty acids and cardiac autonomic function in humans. Cell. Mol. Biol. 2010, 56(1): 131-139.